Sort   by:  
 Page size 
UnknownIdentification of urinary volatile organic compounds as a potential non-invasive biomarker for esophageal cancer.
Not available
S-EPMC10616168 | biostudies-literature
UnknownColorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Not available
S-EPMC6688336 | biostudies-literature
UnknownMACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm.
Not available
S-EPMC8257666 | biostudies-literature
UnknownTranscriptome profiling reveals transcriptional and alternative splicing regulation in the early embryonic development of hair follicles in the cashmere goat.
Not available
S-EPMC6882815 | biostudies-literature
UnknownSerum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Not available
S-EPMC6685266 | biostudies-literature
UnknownDistinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.
Not available
S-EPMC11698706 | biostudies-literature
UnknownTh17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients.
Not available
S-EPMC7275425 | biostudies-literature
UnknownTRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas.
Not available
S-EPMC8223376 | biostudies-literature
UnknownA novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation.
Not available
S-EPMC7465408 | biostudies-literature
Unknownm6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer.
Not available
S-EPMC8579518 | biostudies-literature
Sort   by:  
 Page size